Intrapulmonary Distribution of Intravenous Telavancin in Healthy Subjects and Effect of Pulmonary Surfactant on In Vitro Activities of Telavancin and Other Antibiotics

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2008-01, Vol.52 (1), p.92-97
Hauptverfasser:	GOTFRIED, Mark H, SHAW, Jeng-Pyng, BENTON, Bret M, KRAUSE, Kevin M, GOLDBERG, Michael R, KITT, Michael M, BARRIERE, Steven L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aminoglycosides Aminoglycosides - administration & dosage Aminoglycosides - adverse effects Aminoglycosides - pharmacokinetics Aminoglycosides - pharmacology Anti-Bacterial Agents Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Bronchoalveolar Lavage Fluid - cytology Bronchoscopy Female Humans Injections, Intravenous Lung Lung - chemistry Lung - drug effects Lung - metabolism Macrophages, Alveolar - cytology Male Medical sciences Methicillin Resistance Microbial Sensitivity Tests Pharmacology Pharmacology. Drug treatments Pulmonary Surfactants Pulmonary Surfactants - pharmacology Staphylococcus aureus Staphylococcus aureus - drug effects Streptococcus pneumoniae Streptococcus pneumoniae - drug effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!